Yat Sun Or
Vermogen: 5 M $ op 31-05-2026
Vermogen: 5 M $ op 31-05-2026
Yat Sun Or currently works at Enanta Pharmaceuticals, Inc., as CSO, Senior Vice President-Research & Development from 1999.
Dr. Or also formerly worked at Abbott Laboratories, as Principal and Schering-Plough Pharmaceuticals, as Member-Cardiovascular Drug Discovery Team.
Dr. Or received his doctorate degree in 1980 from The University of Chicago.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-02-2026 | 374.854 ( 1,29% ) | 5 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-1999 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Schering-Plough Pharmaceuticals | Portfolio Manager-Fixed Income | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
Schering-Plough Pharmaceuticals |
Kies jouw editie
Alle financiële informatie op nationaal niveau